Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

Wastewater surveillance suggests that we in the midst of what's being called a "Silent" COVID-19 surge fueled by the XEC ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the ...

The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...

Anumigilimab is under clinical development by CSL and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the ...

The U.S. Food and Drug Administration has revoked the Emergency Use Authorization for bamlanivimab administered alone, bamlanivimab and ...

Press Release - Vaccination remains an important public health countermeasure against COVID-19. As per the WHO Director ...

An MOH spokesman said that in general, the Covid-19 situation here has been stable. Read more at straitstimes.com.

Dec 23 (Reuters) - The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly (LLY.N), opens new tab ...